The mucosal immune system and HIV-1 infection

AIDS Reviews

Volumn 5, Issue 4, 2003, Pages 245-252

  Veazey, Ronald ^a   Lackner, Andrew ^a  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

AIDS; HIV 1; Immunology; Mucosal immunity; SIV

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CCR5; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTEGRIN; LYMPHOCYTE ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; DISEASE COURSE; HELPER CELL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNE SYSTEM; LYMPHOCYTE ACTIVATION; LYMPHOID TISSUE; MUCOSA; NONHUMAN; OPPORTUNISTIC INFECTION; PATHOGENESIS; PROTEIN EXPRESSION; REVIEW; T LYMPHOCYTE; VIRUS REPLICATION; VIRUS TRANSMISSION;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; HIV INFECTIONS; HIV-1; HUMANS; IMMUNITY, MUCOSAL; INTESTINAL MUCOSA; MACACA MULATTA; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 1342308333     PISSN: 11396121     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (83)

1. Miller C, Shattock R. Target cells in vaginal HIV transmission. Microbes & Infection 2003;5:59-67.
2. Mestecky J, Bienenstock J, McGhee J, Lamm M, Strober W, Ogra P. Historical aspects of mucosal immunology. In: Mestecky J, Bienenstock J, McGhee J, Lamm M, Strober W, Ogra P (eds). Mucosal Immunology. 2nd ed. San Diego: Academic Press 1999:xix-xliii.
3. Brandtzaeg P. Overview of the mucosal immune system. Curr Top Microbiol Immunol 1989;146:13-25.
4. Cerf-Bensussan N, Guy-Grand D. Intestinal intraepithelial lymphocytes. Gastroenterol Clin North Am 1991;20:549-75.
5. Mowat AM, Viney JL. The anatomical basis of intestinal immunity. Immunol Rev 1997;156:145-66.
6. Rocha B, Vassalli P, Guy-Grand D. The Vb repertoire of mouse gut homodimeric a CD8+ intraepithelial T-cell receptor a/b+ lymphocytes reveals a major extrathymic pathway of T-cell differentiation. J Exp Med 1991;173:483-6.
7. Brandtzaeg P, Farstad I, Johansen F, Morton H, Norderhaug I, Yamanaka T. The B-cell system of human mucosae and exocrine glands. Immunol Rev 1999;171:45-87.
8. Neutra M, Frey A, Kraehenbuhl J-P. Epithelial M cells: Gateways for mucosal infection and immunity. Cell 1996;86:345-8.
9. Kiyono H, Bienenstock J, McGhee J, Ernst P. The mucosal immune system: Features of inductive and effector sites to consider in mucosal immunization and vaccine development. Regional Immunol 1992;4:54-62.
10. Butcher E, Picker L. Lymphocyte homing and homeostasis. Science 1996;272:60-6.
11. Kunkel E, Butcher E. Chemokines and the tissue-specific migration of lymphocytes. Immunity 2002;16:1-4.
12. Kunkel E, Boisvert J, Murphy K, et al. Expression of the chemokine receptors CCR4, CCR5, and CXCR3 by human tissue-infiltrating lymphocytes. Amer J Pathol 2002;160:347-55.
13. Cepek K, Parker C, Madara J, Brenner M. Integrin aEb7 mediates adhesion of T lymphocytes to epithelial cells. J Immunol 1993;150:3459-70.
14. Olaussen R, Farstad I, Brandtzaeg P, Rugtveit J. Age-related changes in CCR9+ circulating lymphocytes: Are CCR9+ naive T-cells recent thymic emigrants? Scand J Immunol 2001;54:435-9.
15. Kunkel E, Kim C, Lazarus N, et al. CCR10 expression is a common feature of circulating and mucosal epithelial tissue IgA Ab-secreting cells. J Clin Invest 2003;111:1001-10.
16. Lazarus N, Kunkel E, Johnston B, Wilson E, Youngman K, Butcher E. A common mucosal chemokine (mucosae-associated epithelial chemokine/CCL28) selectively attracts IgA plasmablasts. J Immunol 2003;170:3799-805.
17. Schnittman S, Lane H, Greenhouse J, Justement J, Baseler M, Fauci A. Preferential infection of CD4+ memory cells by HIV type 1: Evidence for a role in the selective T-cell functional defects observed in infected individuals. Proc Natl Acad Sci USA 1990;87:6058-62.
18. McDougal J, Mawle A, Cort S, et al. Cellular tropism of the human retrovirus HTLV-III/LAV. I. Role of T-cell activation and expression of the T4 antigen. J Immunol 1985;135:3151-62.
19. Spina C, Prince H, Richman D. Preferential replication of HIV-1 in the CD45RO memory cell subset of primary CD4 lymphocytes in vitro. J Clin Invest 1997;99:1774-85.
20. Van Noesel C, Gruters R, Terpstra F, Schellekens P, Van Lier R, Miedema F. Functional and phenotypic evidence for a selective loss of memory T-cells in asymptomatic HIV-infected men. J Clin Invest 1990;86:293-9.
21. Poles M, Elliott J, Taing P, Anton P, Chen I. A preponderance of CCR5(+) CXCR4(+) mononuclear cells enhances gastrointestinal mucosal susceptibility to HIV type 1 infection. J Virol 2001;75:8390-9.
22. Veazey R, DeMaria M, Chalifoux L, et al. Gastrointestinal tract as a major site of CD4+ T-cell depletion and viral replication in SIV infection. Science 1998;280:427-31.
23. Kewenig S, Schneider T, Hohloch K, et al. Rapid mucosal CD4+ T-cell depletion and enteropathy in simian immunodeficiency virus-infected rhesus macaques. Gastroenterol 1999;116:1115-23.
24. Veazey R, Marx P, Lackner A. Vaginal CD4+ T-cells express high levels of CCR5 and are rapidly depleted in simian immunodeficiency virus infection. J Infect Dis 2003;187:769-76.
25. Clayton F, Snow G, Reka S, Kotler D. Selective depletion of rectal lamina propria rather than lymphoid aggregate CD4 lymphocytes in HIV infection. Clin Exp Immunol 1997;107:288-92.
26. Lim S, Condez A, Lee C, Johnson M, Elia C, Poulter L. Loss of mucosal CD4 lymphocytes is an early feature of HIV infection. Clin Exp Immunol 1993;92:448-54.
27. Veazey R, Lifson J, Pandrea I, Purcell J, Piatak M, Lackner A. Simian immunodeficiency virus infection in neonatal macaques. J Virol 2003;77:8783-92.
28. Doms R. Chemokine receptors and HIV entry. AIDS 2001;15(Suppl 1):34-5.
29. Deng H, Liu R, Ellmeier W, et al. Identification of a major coreceptor for primary isolates of HIV-1. Nature 1996;381:661-6.
30. Dragic T, Litwin V, Allaway G, et al. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature 1996;381:667-73.
31. Cocchi F, DeVico A, Garzino-Demo A, Arya S, Gallo R, Lusso P. Identification of RANTES, MIP-1a, and MIP-1b as the major HIV-suppressor factors produced by CD8+ T-cells. Science 1995;270:1811-5.
32. Thorpe R. Chemokine/chemokine receptor nomenclature. J Immunol Methods 2002;262:1-3.
33. Feng Y, Broder C, Kennedy P, Berger E. HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 1996;272:872-7.
34. Berger E, Murphy P, Farber J. Chemokine receptors as HIV-1 coreceptors: Roles in viral entry, tropism, and disease. Ann Rev Immunol 1999;17:657-700.
35. Penn M, Grivel J, Schramm B, Goldsmith M, Margolis L. CXCR4 utilization is sufficient to trigger CD4+ T-cell depletion in HIV-1-infected human lymphoid tissue. Proc Natl Acad Sci USA 1999;96:663-8.
36. Connor R, Sheridan K, Ceradini D, Choe S, Landau N. Change in coreceptor use correlates with disease progression in HIV-1 - Infected individuals. J Exp Med 1997;185:621-8.
37. Anton P, Elliott J, Poles M, et al. Enhanced levels of functional HIV-1 co-receptors on human mucosal T-cells demonstrated using intestinal biopsy tissue. AIDS 2000;14:1761-5.
38. Veazey R, Marx P, Lackner A. The mucosal immune system: Primary target for HIV infection and AIDS. Trends Immunol 2001;22:626-33.
39. Veazey R, Mansfield K, Tham I, et al. Dynamics of CCR5 expression by CD4(+) T-cells in lymphoid tissues during simian immunodeficiency virus infection. J Virol 2000;74:11001-7.
40. Lapenta C, Boirivant M, Marini M, et al. Human intestinal lamina propria lymphocytes are naturally permissive to HIV-1 infection. Eur J Immunol 1999;29:1202-8.
41. Meng G, Sellers M, Mosteller-Barnum M, Rogers T, Shaw G, Smith P. Lamina propria lymphocytes, not macrophages, express CCR5 and CXCR4 and are the likely target cell for HIV type 1 in the intestinal mucosa. J Infect Dis 2000;182:785-91.
42. Ebert L, McColl S. Up-regulation of CCR5 and CCR6 on distinct subpopulations of antigen-activated CD4+ T lymphocytes. J Immunol 2002;168:65-72.
43. Veazey R, Lackner A. The gastrointestinal tract and the pathogenesis of AIDS. AIDS 1998;12(Suppl A):35-42.
44. Veazey R, Tham I, Mansfield K, et al. Identifying the target cell in primary simian immunodeficiency virus (SIV) infection: Highly activated memory CD4(+) T-cells are rapidly eliminated in early SIV infection in vivo. J Virol 2000;74:57-64.
45. Krzysiek R, Rudent A, Bouchet-Delbos L, et al. Preferential and persistent depletion of CCR5+ T-helper lymphocytes with non-lymphoid homing potential despite early treatment of primary HIV infection. Blood 2001;98:3169-71.
46. Shacklett B, Cox C, Sandberg J, Stollman N, Jacobson M, Nixon D. Trafficking of HIV type 1-specific CD8+ T-cells to gut-associated lymphoid tissue during chronic infection. J Virol 2003;77:5621-31.
47. Clayton F, Reka S, Cronin W, Torlakovic E, Sigal S, Kotler D. Rectal mucosal pathology varies with HIV antigen content and disease stage. Gastroenterol 1992;103:919-33.
48. Kotler D, Reka S, Borcich A, Cronin W. Detection, localization, and quantitation of HIV-associated antigens in intestinal biopsies from patients with HIV. Am J Path 1991;139:823-30.
49. Schneider T, Jahn H-U, Schmidt W, Reicken E-O, Zeitz M, Ulrich R. Loss of CD4 T lymphocytes in patients infected with HIV type 1 is more pronounced in the duodenal mucosa than in the peripheral blood. Gut 1995;37:524-9.
50. Ullrich R, Schmidt W, Zippel T, Schneider T, Zeitz M, Riecken E. Mucosal HIV infection. Pathobiology 1998;66:145-50.
51. Anton P, Mitsuyasu R, Deeks S, et al. Multiple measures of HIV burden in blood and tissue are correlated with each other but not with clinical parameters in aviremic subjects. AIDS 2003;17:53-63.
52. Heise C, Vogel P, Miller C, Halsted C, Dandekar S. Simian immunodeficiency virus infection of the gastrointestinal tract of rhesus macaques. Am J Pathol 1993;142:1759-71.
53. Veazey R, Gauduin M, Mansfield K, et al. Emergence and kinetics of simian immunodeficiency virus-specific CD8(+) T-cells in the intestines of macaques during primary infection. J Virol 2001;75:10515-9.
54. Stevceva L, Kelsall B, Nacsa J, et al. Cervico-vaginal lamina propria lymphocytes: Phenotypic characterization and their importance in cytotoxic T-lymphocyte responses to simian immunodeficiency virus SIVmac251. J Virol 2002;76:9-18.
55. Baig J, Levy D, McKay P, et al. Elicitation of simian immunodeficiency virus-specific cytotoxic T lymphocytes in mucosal compartments of rhesus monkeys by systemic vaccination. J Virol 2002;76:11484-90.
56. Veazey R, Lifson J, Schmitz J, et al. Dynamics of simian immunodeficiency virus-specific cytotoxic T-cell responses in tissues. J Med Primatol 2003;32:194-200.
57. Rosenberg Y, Cafaro A, Brennan T, et al. Characteristics of the CD8+ lymphocytosis during primary simian immunodeficiency virus infections. AIDS 1997;11:959-68.
58. Hel Z, Nacsa J, Trynizewska E, et al. Containment of simian immunodeficiency virus infection in vaccinated macaques: Correlation with the magnitude of virus-specific pre- and post-challenge CD4+ and CD8+ T-cell responses. J Immunol 2002;169:4778-87.
59. Kalams S, Goulder P, Shea A, et al. Levels of HIV type 1-specific cytotoxic T-lymphocyte effector and memory responses decline after suppression of viremia with highly active antiretroviral therapy. J Virol 1999;73:6721-8.
60. Kuroda M, Schmitz J, Charini W, et al. Emergence of CTL coincides with clearance of virus during primary simian immunodeficiency virus infection in rhesus monkeys. J Immunol 1999;162:5127-33.
61. Callan M, Tan L, Annels N, et al. Direct visualization of antigen-specific CD8+ T-cells during the primary immune response to Epstein-Barr virus in vivo. J Exp Med 1998;187:1395-402.
62. Ostrowski M, Justement S, Ehler L, et al. The role of CD4+ T-cell help and CD40 ligand in the in vitro expansion of HIV-1-specific memory cytotoxic CD8+ T-cell responses. J Immunol 2000;165:6133-41.
63. Janssen E, Lemmens E, Wolfe T, Christen U, Von Herrath M, Schoenberger S. CD4+ T-cells are required for secondary expansion and memory in CD8+ T lymphocytes. Nature 2003;421:852-6.
64. Kalams S, Walker B. The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses. J Exp Med 1998;188:2199-204.
65. Frasca L, Piazza C, Piccolella E. CD4+ T-cells orchestrate both amplification and deletion of CD8+ T-cells. Critical Rev Immunol 1998;18:569-94.
66. Leng Q, Borkow G, Weisman Z, Stein M, Kalinkovich A, Bentwich Z. Immune activation correlates better than HIV plasma viral load with CD4 T-cell decline during HIV infection. J Acquir Immune Defic Syndr 2001;27:389-97.
67. Sousa A, Carneiro J, Meier-Schellersheim M, Grossman Z, Victorino RM. CD4 T-cell depletion is linked directly to immune activation in the pathogenesis of HIV-1 and HI-2 but only indirectly to the viral load. J Immunol 2002;169:3400-6.
68. Miao Y, Hayes P, Gotch F, Barrett M, Francis N, Gazzard B. Elevated mucosal address in cell adhesion molecule-1 expression in acquired immunodeficiency syndrome is maintained during antiretroviral therapy by intestinal pathogens and coincides with increased duodenal CD4 T-cell densities. J Infect Dis 2002;185:1043-50.
69. Rosenberg E, Billingsley J, Caliendo A, et al. Vigorous HIV-1-specific CD4+ T-cell responses associated with control of viremia. Science 1997;278:1447-50.
70. Douek D, Brenchley J, Betts M, et al. HIV preferentially infects HIV-specific CD4+ T-cells. Nature 2002;41:95-8.
71. Lehner T, Anton P. Mucosal immunity and vaccination against HIV. AIDS 2002;16(Suppl 4):125-32.
72. Ambrose Z, Thompson J, Larsen K, et al. Evidence for immune-mediated reduction of viral replication in Macaca nemestrina mucosally immunized with inactivated SHIV(89.6). Virology 2003;308:178-90.
73. Belyakov I, Hel Z, Kelsall B, et al. Mucosal AIDS vaccine reduces disease and viral load in gut reservoir and blood after mucosal infection of macaques. Nature Med 2001;7:1320-6.
74. Eo S, Gierynska M, Kamar A, Rouse B. Prime-boost immunization with DNA vaccine: Mucosal route of administration changes the rules. J Immunol 2001;166:5473-9.
75. Belyakov I, Derby M, Ahlers J, et al. Mucosal immunization with HIV-1 peptide vaccine induces mucosal and systemic cytotoxic T lymphocytes and protective immunity in mice against intrarectal recombinant HIV-vaccinia challenge. Proc Natl Acad Sci USA 1998;95:1709-14.
76. Cromwell M, Veazey R, Altman J, et al. Induction of mucosal homing virus-specific CD8+ T lymphocytes by attenuated simian immunodeficiency virus. J Virol 2000;74:8762-6.
77. Kumar A, Mukherjee S, Shen J, et al. Immunization of macaques with live simian human immunodeficiency virus (SHIV) vaccines conferred protection against AIDS induced by homologous and heterologous SHIVs and simian immunodeficiency virus. Virology 2002;301:189-205.
78. Rose N, Marx P, Luckay A, et al. An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants. Cell 2001;106:539-49.
79. Johnson R, Desrosiers R. Protective immunity induced by live attenuated simian immunodeficiency virus. Curr Opin Immunol 1998;10:436-43.
80. Daniel M, Kirchhoff F, Czajak S, Sehgal P, Desrosiers R. Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. Science 1992;258:1938-41.
81. Crotty S, Miller C, Lohman B, et al. Protection against simian immunodeficiency virus vaginal challenge by using Sabin poliovirus vectors. J Virol 2001;75:7435-52.
82. Stevceva L, Álvarez X, Lackner A, et al. Both mucosal and systemic routes of immunization with the live, attenuated NYVAC/simian immunodeficiency virus SIV(gpe) recombinant vaccine result in gag-specific CD8(+) T-cell responses in mucosal tissues of macaques. J Virol 2002;76:11659-76.
83. Moore J, Doms R. The entry of entry inhibitors; A fusion of science and medicine. Proc Natl Acad Sci USA (in press).